<PAGE> 1
As filed with the Securities and Exchange Commission on April 26, 1999
Registration Statement No. 333-27971
- --------------------------------------------------------------------------------
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
POST EFFECTIVE AMENDMENT NO. 1
FORM S-3
Registration Statement Under The Securities Act of 1933
WANG LABORATORIES, INC.
(Exact name of registrant as specified in its charter)
DELAWARE 04-2192707
- ------------------------------- ------------------
(State or other jurisdiction of (I.R.S. Employer
incorporation or organization) Identification No.)
290 CONCORD ROAD
BILLERICA, MASSACHUSETTS 01821
(978) 625-5000
------------------------------
(Address, including Zip Code, and Telephone Number, Including Area Code, of
Registrant's Principal Executive Offices)
ALBERT A. NOTINI, ESQ.
EXECUTIVE VICE PRESIDENT,
GENERAL COUNSEL AND SECRETARY
WANG LABORATORIES, INC.
290 CONCORD ROAD
BILLERICA, MASSACHUSETTS 01821
(978) 625-5000
------------------------------
(Name, Address, Including Zip Code, and Telephone Number,
Including Area Code, of Agent for Service)
Copies to:
PATRICK J. RONDEAU, ESQ.
HALE AND DORR LLP
60 STATE STREET
BOSTON, MASSACHUSETTS 02109
(617) 526-6000
Approximate date of commencement of proposed sale to the public: completed.
If the only securities being registered on this form are being offered pursuant
to dividend or interest reinvestment plans, please check the following box. [ ]
If any of the securities being registered on this form are to be offered on a
delayed or continuous basis pursuant to Rule 415 under the Securities Act of
1933, other than securities offered only in connection with dividend or interest
reinvestment plans, check the following box. [ ]
<PAGE> 2
If this form is filed to register additional securities for an offering pursuant
to Rule 462(b) under the Securities Act, please check the following box and list
the Securities Act registrations statement number of the earlier effective
registration statement for the same offering. [ ]
If this form is a post-effective amendment filed pursuant to Rule 462(c) under
the Securities Act, check the following box and list the Securities Act
registration statement number of the earlier effective registration statement
for the same offering. [ ]
If delivery of the prospectus is expected to be made pursuant to Rule 434,
please check the following box. [ ]
2
<PAGE> 3
This post-effective amendment No. 1 to the Registration Statement to Form
S-3, filed with the Commission on May 29, 1997, as amended on February 11, 1998
(Registration Statement No. 333-27971) (the "Registration Statement") is being
filed for the purpose of deregistering all of the shares of Common Stock, $0.01
par value per share, of Wang Laboratories, Inc. registered pursuant to the
Registration Statement that have not yet been sold thereunder and terminating
the Registration Statement.
3
<PAGE> 4
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the Registrant
certifies that it has reasonable grounds to believe that it meets all of the
requirements for filing on Form S-3 and has duly caused this Registration
Statement to be signed on its behalf by the undersigned, thereunto duly
authorized, in the Town of Billerica, Commonwealth of Massachusetts this 21st
day of April, 1999.
WANG LABORATORIES, INC.
By: /s/ John P. Cunningham
----------------------------------
John P. Cunningham
Executive Vice President
and Chief Financial Officer
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, this
Registration Statement has been signed by the following persons on this 21st day
of April, 1999, in the capacities indicated:
<TABLE>
<CAPTION>
Signature Title Date
<S> <C> <C>
/s/ Joseph M. Tucci* Chairman of the Board, Chief April 21, 1999
- ------------------------------------ Executive Officer and Director
Joseph M. Tucci (Principal Executive Officer)
/s/ John P. Cunningham Executive Vice President April 21, 1999
- ------------------------------------ and Chief Financial Officer
John P. Cunningham (Principal Financial Officer)
/s/Paul F. Brauneis Vice President and Controller April 21, 1999
- ------------------------------------ (Principal Financial Officer and
Paul F. Brauneis Principal Accounting Officer)
/s/ David A. Boucher* Director April 21, 1999
- ------------------------------------
David A. Boucher
/s/ Michael W. Brown* Director April 21, 1999
- ------------------------------------
Michael W. Brown
/s/Roberto Colaninno Director April 21, 1999
- ------------------------------------
Roberto Colaninno
/s/Sergio Erede Director April 21, 1999
- ------------------------------------
Sergio Erede
/s/ Marcia J. Hooper* Director April 21, 1999
- ------------------------------------
Marcia J. Hooper
/s/ Joseph J. Kroger* Director April 21, 1999
- ------------------------------------
Joseph J. Kroger
/s/ Raymond C. Kurzweil* Director April 21, 1999
- ------------------------------------
Raymond C. Kurzweil
/s/ Axel J. Leblois* Director April 21, 1999
- ------------------------------------
Axel J. Leblois
</TABLE>
4
<PAGE> 5
<TABLE>
<S> <C>
/s/ Frederick A. Wang* Director April 21, 1999
- ------------------------------------
Frederick A. Wang
/s/ John P. White Director April 21, 1999
- ------------------------------------
John P. White
*By: /s/ Albert A. Notini
- ----------------------------------------
Albert A. Notini, Attorney-in-Fact
</TABLE>
5
